E-MO Biology Report issue

For profit Phase 4
Founded: Taipei Taiwan (2019)

Organization Overview

First Clinical Trial
2020
NCT04639375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

E-MO Biology Inc

Active Ingredients

Drugs in Phase 4 Trials (1)

Inactivated polio virus - Enhanced (IPOL) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1